Unicentric Form of Castleman Disease - Surgery Therapy Benefit

Castleman Disease - Diagnosis and Surgery

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05440305

Enrollment

Registered

2022-06-30

Start date

2011-01-01

Completion date

2022-04-30

Last updated

2022-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Castleman Disease, Surgery, Unicentric Castleman Disease

Keywords

Unicentric form of Castleman disease, Surgical resection

Brief summary

Observation study on patients with unicentric form of Castleman disease, evaluation of surgical treatment benefit. Observation of surgical treatment strategy.

Interventions

PROCEDUREsurgery type/exstirpation/debulking

Evaluation of benefit according to surgery

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* patient with unicentric form of Castleman disease * underwent surgery resection

Exclusion criteria

* multilocalised Castleman disease

Design outcomes

Primary

Measure	Time frame	Description
5 year survival	each 6 months checkup, up to 150 weeks, from date of randomization until the date of first documented progression	surgery treatment success
recurence rate	each 6 months checkup, up to 150 weeks, from date of randomization until the date of first documented progression	surgery treatment success

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026